Healthcare Services

Next-Generation Sequencing Data Analysis Market Outlook 2026–2030 with Major Growth Drivers and Emerging Industry Trends

April 3, 2026April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Next-Generation Sequencing Data Analysis Market By 2030 Starting From Its 2026 Size?

The next-generation sequencing data analysis market has experienced substantial expansion in recent years. This market is projected to grow from $1.48 billion in 2025 to $1.8 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.9%. The increase observed in the historic period can be attributed to several factors, including the rising volumes of NGS data generation, the expanding utilization of genomic data in research, the broader implementation of clinical sequencing programs, improvements in computational infrastructure, and the growing adoption of outsourced bioinformatics services.

The next-generation sequencing data analysis market size is anticipated to undergo significant expansion in the coming years. Its value is projected to reach $3.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 21.5%. This projected growth stems from several factors, including the greater integration of AI in variant interpretation, a rising demand for real-time genomic insights, the expansion of personalized medicine applications, growing investments in secure genomic data platforms, and an increasing regulatory focus on data compliance. Prominent trends expected during this forecast period encompass the increasing adoption of AI-driven bioinformatics platforms, a rising demand for cloud-based NGS data analysis, the growing use of long-read sequencing analytics, the expansion of integrated genomic pipelines, and an enhanced focus on data interpretation accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19614&type=smp

Which Market Drivers Are Supporting The Expansion Of The Next-Generation Sequencing Data Analysis Market?

The growing incidence of cancer is anticipated to boost the next-generation sequencing data analysis market in the coming period. Cancer refers to a collection of illnesses characterized by the uncontrolled proliferation and spread of abnormal cells within the body, which, if untreated, can potentially lead to severe health issues or fatality. Unhealthy lifestyle habits, including smoking, excessive consumption of alcohol, and diets rich in processed foods and low in fruits and vegetables, can significantly elevate the risk of developing cancer. Next-generation sequencing data analysis supports cancer treatment by enabling the precise identification of genetic mutations, which facilitates personalized therapies and more effective treatment approaches tailored to an individual’s specific cancer genetic profile. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that by 2050, new cancer cases would exceed 35 million, marking a 77% increase compared to the estimated 20 million cases in 2022. Thus, the increasing prevalence of cancer is propelling the expansion of the next-generation sequencing data analysis market.

Which Segment Categories Define The Next-Generation Sequencing Data Analysis Market?

The next-generation sequencing data analysis market covered in this report is segmented –

1) By Product: Services, Next-Generation Sequencing (NGS) Commercial Software

2) By Read Length: Short Read Sequencing, Long Read Sequencing, Very Long Read Sequencing

3) By Mode: In-House, Outsourced

4) By Workflow: Primary, Secondary, Tertiary

5) By End-User: Academic Research, Clinical Research, Hospitals And Clinics, Pharma And Biotech Entities, Other End-Users

Subsegments:

1) By Services: Data Analysis Services, Bioinformatics Services, Consulting Services, Training and Support Services

2) By Next-Generation Sequencing (NGS) Commercial Software: Data Management Software, Alignment Software, Variant Calling Software, Visualization Software, Pipeline Management Software, Specialized Analysis Software

Which Trends Are Impacting The Growth Of The Next-Generation Sequencing Data Analysis Market?

Leading companies in the next-generation sequencing data analysis market are concentrating on developing advanced secondary analysis bioinformatics software. This focus aims to enable quicker and more accurate identification of genetic variants for both research and clinical applications. Secondary analysis bioinformatics software is designed to process raw next-generation sequencing (NGS) data and convert it into interpretable formats, such as variant call files (VCF), which detail genetic variants. This software consequently streamlines NGS data analysis for research and clinical purposes. For instance, in January 2024, QIAGEN Digital Insights, a US-based bioinformatics business of QIAGEN, launched the QIAGEN CLC Genomics Workbench Premium with LightSpeed technology. This software facilitates next-generation sequencing (NGS) for somatic cancer analysis and rapidly processes whole genome sequencing (WGS) samples. It can analyze 34x human genomes in 25 minutes and 50x exomes in 90 seconds using LightSpeed technology, which efficiently converts raw FASTQ data into interpretable formats. With costs as low as $1 for genomes and a few cents for exomes using cloud infrastructure, it presents a cost-effective solution for high-throughput laboratories. The program runs on ordinary hardware or cloud platforms, providing flexibility and excellent accuracy, making it ideal for clinical applications while minimizing its carbon footprint.

Who Are The Top Companies Competing In The Next-Generation Sequencing Data Analysis Market?

Major companies operating in the next-generation sequencing data analysis market are Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., MedGenome Inc., Element Biosciences Inc., Seven Bridges Genomics Inc., Synthego Corp., Eurofins Genomics India Pvt. Ltd., Fabric Genomics Inc., Strand Life Sciences Pvt. Ltd., Admera Health LLC, Congenica Ltd., DNASTAR Inc., Golden Helix Inc., Geneious, SciGenom Labs Pvt. Ltd., Partek Incorporated, PathoQuest SAS, BioDatomics Inc., BGI Genomics Co. Ltd

Read the full next-generation sequencing data analysis market report here:

https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-data-analysis-global-market-report

How Is The Next-Generation Sequencing Data Analysis Market Distributed Across Key Geographic Regions?

North America was the largest region in the next-generation sequencing data analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next-generation sequencing data analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Next-Generation Sequencing Data Analysis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19614&type=smp

Browse Through More Reports Similar to the Global Next-Generation Sequencing Data Analysis Market 2026, By The Business Research Company

Ovarian Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-diagnostics-global-market-report

Cervical Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report

Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795